A majority (78.6%) of the patients had received treatments in their better eye: anti‐VEGF or laser for retinal conditions (AMD, 984; DME, 47; RVO, 149) and corneal cross‐linking (n = 44) for keratoconus. The gene discussed is VEGFA; the disease is age-related macular degeneration.